Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole)

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Cross Contamination with Other Products
Products
  • Abilify (aripiprazole)
Where it was sold

USA nationwide.

Nationwide

Units affected
N/A
About this recall
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13